Grifols | GRFS - Ativo Circulante





Ativo Circulante Alterar Data
Alaunos Therapeutics USD 970K 1.02M 2026-03
Arca Biopharma USD 395.25M 51.39M 2026-03
aTyr Pharma USD 67.58M 178.23M 2026-03
Bio Path USD 677K 14K 2026-03
Brainstorm Cell Therapeutics USD 184K 123K 2026-03
Capricor Therapeutics USD 283.09M 39.85M 2026-03
Cara Therapeutics USD 31.54M 6.9M 2025-12
Esperion Therapeutics USD 459.46M 3.11M 2026-03
GlaxoSmithKline GBP 17.76B 251M 2026-03
Grifols EUR 5.96B 316.31M 2025-12
Immunic USD 188.76M 165.89M 2026-03
Infinity Pharmaceuticals USD 19.91M 8.46M 2023-06
Minerva Neurosciences USD 83.1M 70.08M 2025-12
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Sangamo BioSciences USD 49.89M 12.3M 2025-06
TherapeuticsMD USD 11.82M 303K 2024-06